Bovie Medical swings to 2011 black
Bovie Medical (NYSE:BVX) posted losses of $876,000, or 5¢ per share, on sales of $6.2 million during the 3 months ended Dec. 31, 2011. That compares with losses of $1.4 million, or 8¢ per share, on sales of $6.2 million during the same period in 2010.
For the full year, Bovie reported profits of $109 million, or 1¢ per share, on sales of $25.4 million. That compares with losses of $1.5 million, or 9¢ per share, on sales of $24.2 million during 2010.
Read more
Cambridge Heart’s losses widen in Q4, 2011
Cambridge Heart (NSDQ:CAMH) posted losses of $1.4 million, or 1¢ per share, on sales of $557,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $1.2 million, or 2¢ per share, on sales of $714,000 during the same period in 2010.
For the full year, Cambridge Heart reported losses of $5.4 million, or 5¢ per share, on sales of $2.2 million. That compares with losses of $5.2 million, or 7¢ per share, on sales of $2.8 million during 2010.
Read more
Daxor moves to 2011 red
Daxor (NYSE:DXR) posted losses of $7.2 million, or $1.70 per share, on sales of $1.4 million during the 12 months ended Dec. 31, 2011. That compares with profits of $5.0 million, or $1.17 per share, on sales of $1.6 million during 2010.
Read more
Dehaier’s Q4, 2011 profits slide
Dehaier Medical Systems (NSDQ:DHRM) posted profits of $99,000, or -1¢ per share, on sales of $5.4 million during the 3 months ended Dec. 31, 2011. That compares with profits of $1.8 million, or 32¢ per share, on sales of $6.7 million during the same period in 2010.
For the full year, Dehaier reported profits of $4.2 million, or 69¢ per share, on sales of $21.6 million. That compares with profits of $5.2 million, or $1.09 per share, on sales of $19.6 million during 2010.
Read more
Losses soar for Derma Sciences
Derma Sciences (NSDQ:DSCI) posted losses of $2.5 million, or 23¢ per share, on sales of $16.5 million during the 3 months ended Dec. 31, 2011. That compares with losses of $347,000 million, or 5¢ per share, on sales of $15.3 million during the same period in 2010.
For the full year, Derma Sciences reported losses of $4.3 million, or 49¢ per share, on sales of $62.6 million. That compares with losses of $2.4 million, or 39¢ per share, on sales of $56.5 million during 2010.
Read more
Echo Therapeutics’s 2011 losses rise
Echo Therapeutics (NSDQ:ECTE) posted losses of $16.7 million, or 49¢ per share during the 3 months ended Dec. 31, 2011. That compares with losses of $4.3 million, or 15¢ per share, during the same period in 2010.
Read more
EDAP narrows Q4, 2011 losses
EDAP (NSDQ:EDAP) posted losses of $779,000, or 6¢ per share, on sales of $10.1 million during the 3 months ended Dec. 31, 2011. That compares with losses of $9.7 million, or 74¢ per share, on sales of $10.8 million during the same period in 2010.
For the full year, EDAP reported losses of $1.3 million, or $1.10 per share, on sales of $31.2 million. That compares with losses of $16.8 million, or $1.29 per share, on sales of $30.6 million during 2010.
Read more
Sales slide, losses soar for Guided Therapeutics
Guided Therapeutics (OTC:GTHP) posted losses of $2.8 million, or 5¢ per share, on sales of $921,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $280,000, or 1¢ per share, on sales of $1.1 million during the same period in 2010.
For the full year, Guided Therapeutics reported losses of $6.6 million, or 14¢ per share, on sales of $3.6 million. That compares with losses of $4.5 million, or 12¢ per share, on sales of $3.4 million during 2010.
Read more
Kips Bay Medical pares 2011 losses
Kips Bay Medical (NSDQ:KIPS) posted losses of $1.1 million, or 7¢ per share, on sales of $94,000 during the 3 months ended Dec. 31, 2011. That compares with losses of $803,000, or 6¢ per share, on sales of $116,000 during the same period in 2010.
For the full year, Kips Bay reported losses of $4.3 million, or 27¢ per share, on sales of $252,000. That compares with losses of $10.9 million, or 81¢ per share, on sales of $223,000 during 2010.
Read more
Profits plunge for Lumenis
Lumenis posted profits of $690,000, or 0¢ per share, on sales of $247.0 million during 2011. That compares with profits of $5.7 million, or 3¢ per share, on sales of $237.7 million during 2010.
Read more
Mazor Robotics boosts sales, pares Q4 losses
Mazor Robotics (PINK:MZRTF) posted losses of $1.3 million, or 6¢ per share, on sales of $1.8 million during the 3 months ended Dec. 31, 2011. That compares with losses of $1.8 million, or 7¢ per share, on sales of $1.3 million during the same period in 2010.
For the full year, Mazor reported losses of $7.8 million, or 36¢ per share, on sales of $5.8 million. That compares with losses of $6.1 million, or 32¢ per share, on sales of $4.2 million during 2010.
Read more
Sales, losses fall for Nephros
Nephros (OTC:NEPH) posted losses of $2.4 million, or 27¢ per share, on sales of $2.2 million during 2011. That compares with losses of $1.9 million, or 93¢ per share, on sales of $2.9 million during 2010.
Read more
Non Invasive Monitoring Systems halves losses, doubles sales
Non Invasive Monitoring Systems (OTC:NIMU) posted losses of $106,000, or 0¢ per share, on sales of $89,000 during 2011. That compares with losses of $311,000, also 0¢ per share, on sales of $187,000 during 2010.
Read more
Patient Safety Technologies slides to 2011 red
Patient Safety Technologies (OTC:PSTX) posted losses of $2.4 million, or 8¢ per share, on sales of $9.5 million during 2011. That compares with profits of $1.8 million, or 6¢ per share, on sales of $14.8 million during 2010.
Read more
Response Biomedical halves 2011 losses
Response Biomedical (TSE:RBM) posted losses of $5.4 million, or 14¢ per share, on sales of $9.0 million during 2011. That compares with losses of $10.1 million, or 32¢ per share, on sales of $6.8 million during 2010.
Read more
Sanuwave cuts losses
Sanuwave Health (OTC:SNWV) posted losses of $10.2 million, or 52¢ per share, on sales of $803,000 during 2011. That compares with losses of $15.2 million, or $1.15 per share, on sales of $728,000 during 2010.
Read more
Losses rise, sales fall for Stereotaxis
Stereotaxis (NSDQ:STXS) posted losses of $32.0 million, or 58¢ per share, on sales of $42.0 million during 2011. That compares with losses of $19.9 million, or 39¢ per share, on sales of $54.1 million during 2010.
Read more
Tengion’s 2011 losses rise
Tengion (NSDQ:TNGN) posted losses of $5.9 million, or 48¢ per share, during the 3 months ended Dec. 31, 2011. That compares with losses of $14.0 million, or 59¢ per share during 2010.
For the full year, Tengion reported losses of $25.6 million, or $3.22 per share, compared with losses of $19.1 million, or 88¢ per share, during 2010.
Read more
Vasomedical’s losses soar
Vasomedical (PINK:VASO) posted losses of $4.3 million, or 4¢ per share, on sales of $16.7 million during 2011. That compares with losses of $1.9 million, or 2¢ per share, on sales of $4.2 million during 2010.
Read more
Sales up, profits down for Young Innovations
Young Innovations (NSDQ:YDNT) posted profits of $16.5 million, or $2.06 per share, on sales of $106.2 million during 2011. That compares with profits of $17.9 million, or $1.87 per share, on sales of $102.8 million during 2010.
Read more
